VOGLIGOLD G3 M0.3

VOGLIGOLD G3 M0.3 is a triple-drug combination formulated for the management of Type 2 Diabetes Mellitus. It contains:

• Voglibose – an alpha-glucosidase inhibitor that delays carbohydrate absorption in the intestines, controlling post-meal blood sugar spikes.

• Glimepiride – a sulfonylurea that stimulates the pancreas to release more insulin, helping lower fasting and postprandial glucose levels.

• Metformin Hydrochloride – a biguanide that reduces glucose production in the liver and improves insulin sensitivity, helping control fasting blood sugar levels.

This triple combination provides comprehensive blood sugar control by acting on different mechanisms, making it ideal for patients who do not achieve adequate control with dual therapy.

Uses of Glimepiride, Voglibose & Metformin Hydrochloride Tablets

The main glimepiride voglibose and metformin hydrochloride tablets uses include:

• Management of Type 2 Diabetes Mellitus.

• Control of fasting blood sugar (FBS) and postprandial blood sugar (PPBS).

• Reduction in the risk of long-term diabetes complications such as neuropathy, nephropathy, retinopathy, and cardiovascular diseases.

• Often prescribed for patients not responding adequately to single or dual oral anti-diabetic therapy.

Side Effects of VOGLIGOLD G3 M0.3

Common Side Effects:

• Flatulence (gas)

• Abdominal discomfort or bloating

• Diarrhea

• Nausea or vomiting

• Loss of appetite

• Metallic taste in the mouth

• Mild skin rash or itching

• Headache

Less Common Side Effects:

• Fatigue or weakness

• Constipation

• Indigestion

• Dizziness

• Increased bowel sounds (borborygmi)

Serious Side Effects (Rare):

• Hypoglycemia (low blood sugar) – more likely with glimepiride and when combined with other anti-diabetic drugs.

• Lactic acidosis – rare but serious effect of metformin, especially in patients with kidney issues.

• Severe allergic reactions (skin swelling, breathing difficulty).

Precautions Before Using VOGLIGOLD G3 M0.3

Before starting glimepiride voglibose and metformin hydrochloride tablets, inform your doctor if you:

• Have kidney or liver disease.

• Have a history of heart disease or breathing problems.

• Suffer from intestinal disorders or past bowel obstruction.

• Consume alcohol frequently (increases risk of lactic acidosis).

• Are pregnant, breastfeeding, or planning to conceive.

• Have known allergies to voglibose, glimepiride, metformin, or similar drugs.

Drug Interactions – What Drugs Interact with VOGLIGOLD G3 M0.3?

Certain medicines can interact with glimepiride voglibose and metformin hydrochloride tablets:

• Other anti-diabetic drugs (e.g., sulfonylureas, insulin) – may increase hypoglycemia risk.

• Diuretics – may affect blood sugar control and increase lactic acidosis risk.

• Corticosteroids – may raise blood sugar levels.

• Beta-blockers – may mask symptoms of hypoglycemia.

• ACE inhibitors – may enhance the blood sugar-lowering effect.

• Iodinated contrast agents – may cause kidney problems and lactic acidosis.

• Digestive enzymes (e.g., amylase, pancreatin) – may reduce voglibose’s effect.